AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
EP 119 | Q3 Earnings from $JNJ $ASML $CAST & many more!
Dividend Talk
I'm a Big Fan of Johnson and I Think It's a Good Thing They're Doing a Lot Better in Europe Than the US
3min Snip
00:00
Summary
Transcript
Episode notes
The company has restructured rebranded they are now not as reliant on their cancer drugs. The new products are really really starting to earn nearly 50 60% of their the revenue which is quite interesting. diagnostics this division is doing really well we know they invest heavily in R&D and pushing boundaries.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode